Lunai Bioworks Net Income 2013-2026 | LNAI
Lunai Bioworks net income from 2013 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
Lunai Bioworks Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $-178 |
| 2024 | $-88 |
| 2023 | $-40 |
| 2022 | $-113 |
| 2021 | $-27 |
| 2020 | $-11 |
| 2019 | $-18 |
| 2018 | $-6 |
| 2017 | $-2 |
| 2016 | $-2 |
| 2014 | $-2 |
| 2014 | $-2 |
| 2013 | $-2 |
| 2013 | $-2 |
|
Lunai Bioworks Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2026-03-31 | $-3 |
| 2025-12-31 | $-2 |
| 2025-09-30 | $3 |
| 2025-06-30 | $-127 |
| 2025-03-31 | $0 |
| 2024-12-31 | $-7 |
| 2024-09-30 | $-44 |
| 2024-06-30 | $-16 |
| 2024-03-31 | $-59 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $-9 |
| 2023-06-30 | $-23 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-90 |
| 2022-03-31 | $-6 |
| 2021-12-31 | $-7 |
| 2021-09-30 | $-10 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-4 |
| 2020-12-31 | $-3 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-4 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-4 |
| 2019-06-30 | $1 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-16 |
| 2018-09-30 | $0 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-1 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-1 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-03-31 | $-1 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $0 |
| 2013-09-30 | $0 |
| 2013-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.000B |
| Lunai Bioworks Inc. is an AI-powered drug discovery and biodefense company. Lunai Bioworks Inc., formerly known as RENOVARO INC, is based in LOS ANGELES. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Hims & Hers Health (HIMS) | United States | $6.507B | 0.00 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Veradigm (MDRX) | United States | $0.587B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |